Developer docs
API playgroundTry for free, no card

Search company profiles

AccuVein

Full company profile

uuid00027cc

Namestring
AccuVein
Legal namestring
AccuVein Inc.
Websiteurl
accuvein.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

AccuVein is a privately held medical device company headquartered in Medford, New York, that develops and commercializes handheld near-infrared (NIR) vein visualization systems for clinical vascular access. The company's core technology projects a real-time map of subcutaneous vasculature onto a patient's skin, enabling clinicians to locate veins for venipuncture, IV insertion, and other vascular access procedures. Its current product line consists of the AV500 (launched 2019) and the AV600 (launched March 2026) handheld Class 1 laser devices, supplemented by accessories including the HF580 Powered Stand, HF510 Pole Mount Arm, and MRK-100 Vein Assessment Marker, with the AV300 and AV400 models plus the HF550/HF570 hospital-grade units having been discontinued. AccuVein reports 53+ issued US patents and 12+ international patents underlying its technology, and reports a documented installed base of more than 5,000 facilities across 130+ countries.

The company's business model centers on hardware sales of capital equipment, complemented by recurring revenue from service plans, short-term rentals, and accessories. Go-to-market is executed through direct sales, authorized representatives, and contractual relationships with major US healthcare group purchasing organizations (Intalere, Vizient, Premier, Healthtrust) as well as GSA Advantage for federal customers, plus international distributors and an OEM partnership with Greiner Bio-One for blood collection integration. End customers span community hospitals (e.g., Sparrow Hospital, Carle Foundation, Queen of the Valley), cancer and oncology infusion centers, and medical aesthetics practices, where the device is positioned to reduce PIV procedure time, increase first-attempt cannulation success, and lower patient pain scores. AccuVein employs 101-250 people and has raised approximately $87M+ in disclosed funding across multiple rounds from 2011 through 2022, with the current C-suite (CEO Chris Hutchison, CFO Kevin McArdle, CCO Philip Spiegel, COO Brad Washburne, CMO Tom Hopkins) recruited in 2020 from Cheetah Medical following its acquisition by Baxter.

Short descriptiontext

AccuVein is a Medford, NY-based medical device company that develops handheld near-infrared vein visualization systems (AV500, AV600) used by hospitals, cancer centers, and aesthetics practices to improve vascular access success rates across more than 5,000 facilities in 130+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMedford, United States
HQ citystring
Medford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vein visualization systems, near-infrared medical devices, peripheral IV access equipment, vascular access technology, medical imaging devices
Industry1 code
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices (Vein Visualization)
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Vein Visualization Device Sales
TypeHardware Sales
Description

Sale of AV500 and AV600 vein visualization devices as capital equipment purchases to healthcare facilities. Devices are available through direct sales, authorized representatives, and GPO contracts.

accuvein.com
2Accessories and Consumables
TypeHardware Sales
Description

Sales of accessories including HF580 Powered Stand, HF510 Pole Mount Arm, and MRK-100 Vein Assessment Markers (disposable skin marking pens).

accuvein.com
3Service Plans
TypeSubscription Recurring
Description

Platinum Service Plan and warranty offerings for device maintenance and support.

accuvein.com
4Short-term Rentals
TypeSubscription Recurring
Description

Short-term device rental program for temporary large-scale access during pandemic response or other temporary needs.

accuvein.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

AccuVein designs, manufactures, and sells near-infrared (NIR) laser-based vein visualization medical devices that project a real-time map of superficial veins, valves, and bifurcations onto a patient's skin. Its core products are the AV500 and AV600 handheld vein illumination systems, complemented by hands-free stands (HF580), pole-mount arms (HF510), and disposable vein assessment markers (MRK-100). Devices are sold primarily to hospitals, non-acute care facilities, and aesthetic practices for peripheral IV access, phlebotomy, infusion therapy, and cosmetic injectables.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 78% reduction in PIV procedure time
+7 more records
Product overview1 text field

AccuVein offers a portfolio of near-infrared (NIR) vein visualization devices and supporting accessories. The core products are the AV600 (fourth generation, launched 2026) and AV500 (third generation, released 2019) - both Class 1 laser-based handheld devices that project real-time vein maps onto the skin surface using patented True Center technology. These are complemented by hands-free accessories including the HF580 Powered Stand (wheeled with charging) and HF510 Pole Mount Arm, plus the MRK-100 disposable vein assessment marker. Earlier generations (AV300, AV400) and older accessories (HF550, HF570) have been discontinued.

Product and service6 records
1AccuVein AV600 Vein Visualization System
CategoryCore product - Vein visualization system
Description

Fourth generation Class 1 near-infrared laser-based vein visualization device that projects a real-time map of veins, valves, and bifurcations on the skin surface through bright green image projection. Features patented True Center technology with factory-set alignment, weighs 10 ounces (283g), and supports handheld or hands-free use. Targeted at hospitals, non-acute care facilities, and aesthetic practices for peripheral IV access, phlebotomy, infusion therapy, and cosmetic injectables.

2AccuVein AV500 Vein Visualization System
CategoryCore product - Vein visualization system
Description

Third generation Class 1 near-infrared laser-based vein visualization device that projects a real-time map of veins, valves, and bifurcations on the skin surface through bright green image projection. Features True Center technology with factory alignment and no end-user calibration required. Weighs 10 ounces (275g), with three brightness settings and inverse color mode display.

3HF580 Powered Stand
CategoryAccessory
Description

Flexible wheeled stand with built-in charging capability for hands-free and mobile applications of the AV500/AV600 Vein Visualization System. Features adjustable height positioning, smooth arm rotation, break-away power cord, and lockable ergonomic stand wheels. Serviceable at the user's facility.

4HF510 Pole Mount Arm
CategoryAccessory
Description

Portable hands-free solution for the AV500 Vein Visualization System with a clamp attachment for rounded bedrails, IV poles, or flat surfaces. Includes quick-release device-holder and flexible arm design for adjustable positioning.

5MRK-100 Vein Assessment Marker
CategoryAccessory (consumable)
Description

Medical-grade, FDA-registered disposable skin marking pen with EZ Removable Ink for non-surgical procedures including IV access. White colored ink is highly visible under near-infrared light; used to mark venous valves, bifurcations, and catheter insertion site locations. Latex free.

6Platinum Service Plan
CategoryService plan
Description

Recurring service plan and warranty offering for AccuVein device maintenance, repair, and customer support, sold alongside AV500/AV600 vein visualization devices to healthcare facilities.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AccuVein is an awarded supplier of Intalere, a Group Purchasing Organization, enabling contracted sales to Intalere member healthcare facilities.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AccuVein is an awarded supplier of Vizient, a Group Purchasing Organization, enabling contracted sales to Vizient member healthcare systems.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AccuVein is an awarded supplier of Premier, a Group Purchasing Organization, enabling contracted sales to Premier member healthcare facilities.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AccuVein is an awarded supplier on GSA Advantage (contract V797P-4319B), enabling government healthcare facilities to purchase through federal supply schedules.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AccuVein is an awarded supplier of Healthtrust, a Group Purchasing Organization, enabling contracted sales to Healthtrust member healthcare facilities.

Strategic tierStrategicTypeOEM/ Whitelabel/ Licensing Partner
Description

Original Equipment Manufacturer agreement with Greiner Bio-One to bring AccuVein's vein visualization technology to South American markets under the Greiner Bio-One AV400 Vein Scanner brand.

Strategic tierMinorTypeOthers
Description

Emergo UL Europe serves as AccuVein's authorized representative in Europe for regulatory compliance purposes.

Strategic tierMinorTypeOthers
Description

Emergo Australia serves as AccuVein's authorized representative in Australia for regulatory compliance purposes.

Strategic tierMinorTypeOthers
Description

Emergo Consulting (UK) Limited serves as AccuVein's authorized representative in the United Kingdom for regulatory compliance purposes.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with AVA for continuing education programs, CE-accredited webinars, and annual scientific meeting presentations showcasing AccuVein technology and clinical evidence.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufacturer of the VeinViewer line of NIR-based vein visualization devices. Direct competitor to AccuVein's AV500/AV600, targeting the same hospital, non-acute, and aesthetics segments with similar handheld projection technology.

2VueTek Scientific (Veinlite)
TypeDirect peer
Description

Producer of Veinlite transillumination devices for vein access. Competes directly with AccuVein in phlebotomy, PIV access, and sclerotherapy use cases, with overlapping customer base of nurses, phlebotomists, and aesthetics practitioners.

TypeEmerging player
Description

Emerging manufacturer of NIR vein visualization technology offering handheld vein finders to acute-care and outpatient facilities. A newer entrant competing on similar clinical use cases to AccuVein's AV series.

4Illumivein
TypeEmerging player
Description

Smaller player in NIR vein visualization devices aimed at hospitals, blood draw centers, and aesthetics clinics. Competes in the same peripheral IV access niche as AccuVein with a more limited global footprint.

TypeBroad incumbent
Description

Global medical technology incumbent with a broad vascular access portfolio including PIVC catheters, ultrasound-guided IV systems, and integrated vein access solutions. Competes with AccuVein across the hospital vascular access workflow.

TypeBroad incumbent
Description

Large incumbent in IV therapy, infusion systems, and vascular access. Overlaps with AccuVein's hospital PIV and infusion-center customer base and offers competing adjunct technologies like ultrasound guidance for difficult IV access.

TypeBroad incumbent
Description

Major vascular access and interventional medical device company with a portfolio including PICC lines, central venous catheters, and difficult IV access solutions. Competes in the same clinical workflow as AccuVein.

TypeBroad incumbent
Description

Global medical products company (acquired AccuVein CEO Hutchison's prior company, Cheetah Medical). Competes in hospital infusion, IV therapy, and patient monitoring segments where AccuVein's vein visualization devices are deployed.

TypeBroad incumbent
Description

Large medical device manufacturer with an extensive IV therapy, vascular access, and infusion portfolio. Serves the same hospital and non-acute customers that adopt AccuVein's vein visualization technology.

TypeEmerging player
Description

Point-of-care ultrasound vendor increasingly used for guided peripheral IV access in hospitals. Represents a competing modality to AccuVein's NIR-based visualization in the difficult IV access workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AccuVein

Medical Devices (Vein Visualization)accuvein.com

AccuVein is a Medford, NY-based medical device company that develops handheld near-infrared vein visualization systems (AV500, AV600) used by hospitals, cancer centers, and aesthetics practices to improve vascular access success rates across more than 5,000 facilities in 130+ countries.

What AccuVein does

AccuVein is a privately held medical device company headquartered in Medford, New York, that develops and commercializes handheld near-infrared (NIR) vein visualization systems for clinical vascular access. The company's core technology projects a real-time map of subcutaneous vasculature onto a patient's skin, enabling clinicians to locate veins for venipuncture, IV insertion, and other vascular access procedures. Its current product line consists of the AV500 (launched 2019) and the AV600 (launched March 2026) handheld Class 1 laser devices, supplemented by accessories including the HF580 Powered Stand, HF510 Pole Mount Arm, and MRK-100 Vein Assessment Marker, with the AV300 and AV400 models plus the HF550/HF570 hospital-grade units having been discontinued. AccuVein reports 53+ issued US patents and 12+ international patents underlying its technology, and reports a documented installed base of more than 5,000 facilities across 130+ countries.

The company's business model centers on hardware sales of capital equipment, complemented by recurring revenue from service plans, short-term rentals, and accessories. Go-to-market is executed through direct sales, authorized representatives, and contractual relationships with major US healthcare group purchasing organizations (Intalere, Vizient, Premier, Healthtrust) as well as GSA Advantage for federal customers, plus international distributors and an OEM partnership with Greiner Bio-One for blood collection integration. End customers span community hospitals (e.g., Sparrow Hospital, Carle Foundation, Queen of the Valley), cancer and oncology infusion centers, and medical aesthetics practices, where the device is positioned to reduce PIV procedure time, increase first-attempt cannulation success, and lower patient pain scores. AccuVein employs 101-250 people and has raised approximately $87M+ in disclosed funding across multiple rounds from 2011 through 2022, with the current C-suite (CEO Chris Hutchison, CFO Kevin McArdle, CCO Philip Spiegel, COO Brad Washburne, CMO Tom Hopkins) recruited in 2020 from Cheetah Medical following its acquisition by Baxter.

AccuVein firmographics

Firmographics
Name
AccuVein
Legal name
AccuVein Inc.
Website
https://accuvein.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Short description
AccuVein is a Medford, NY-based medical device company that develops handheld near-infrared vein visualization systems (AV500, AV600) used by hospitals, cancer centers, and aesthetics practices to improve vascular access success rates across more than 5,000 facilities in 130+ countries.
Ownership category
akta.pro rank

AccuVein industry classification

Industry
Product category
Medical Devices (Vein Visualization)
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)

Keywords

  • Vein visualization systems
  • Near-infrared medical devices
  • Peripheral IV access equipment
  • Vascular access technology
  • Medical imaging devices

Where AccuVein is headquartered

Location

Headquarters

HQ city
Medford
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AccuVein business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Vein Visualization Device Sales: Sale of AV500 and AV600 vein visualization devices as capital equipment purchases to healthcare facilities. Devices are available through direct sales, authorized representatives, and GPO contracts.
  2. Accessories and Consumables: Sales of accessories including HF580 Powered Stand, HF510 Pole Mount Arm, and MRK-100 Vein Assessment Markers (disposable skin marking pens).
  3. Service Plans: Platinum Service Plan and warranty offerings for device maintenance and support.
  4. Short-term Rentals: Short-term device rental program for temporary large-scale access during pandemic response or other temporary needs.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

AccuVein product offering

Product offering

Core offering

AccuVein designs, manufactures, and sells near-infrared (NIR) laser-based vein visualization medical devices that project a real-time map of superficial veins, valves, and bifurcations onto a patient's skin. Its core products are the AV500 and AV600 handheld vein illumination systems, complemented by hands-free stands (HF580), pole-mount arms (HF510), and disposable vein assessment markers (MRK-100). Devices are sold primarily to hospitals, non-acute care facilities, and aesthetic practices for peripheral IV access, phlebotomy, infusion therapy, and cosmetic injectables.

Product overview

AccuVein offers a portfolio of near-infrared (NIR) vein visualization devices and supporting accessories. The core products are the AV600 (fourth generation, launched 2026) and AV500 (third generation, released 2019) - both Class 1 laser-based handheld devices that project real-time vein maps onto the skin surface using patented True Center technology. These are complemented by hands-free accessories including the HF580 Powered Stand (wheeled with charging) and HF510 Pole Mount Arm, plus the MRK-100 disposable vein assessment marker. Earlier generations (AV300, AV400) and older accessories (HF550, HF570) have been discontinued.

Differentiator

Problem solved

Functional benefit

Products and services

  • AccuVein AV600 Vein Visualization System Fourth generation Class 1 near-infrared laser-based vein visualization device that projects a real-time map of veins, valves, and bifurcations on the skin surface through bright green image projection. Features patented True Center technology with factory-set alignment, weighs 10 ounces (283g), and supports handheld or hands-free use. Targeted at hospitals, non-acute care facilities, and aesthetic practices for peripheral IV access, phlebotomy, infusion therapy, and cosmetic injectables.
  • AccuVein AV500 Vein Visualization System Third generation Class 1 near-infrared laser-based vein visualization device that projects a real-time map of veins, valves, and bifurcations on the skin surface through bright green image projection. Features True Center technology with factory alignment and no end-user calibration required. Weighs 10 ounces (275g), with three brightness settings and inverse color mode display.
  • HF580 Powered Stand Flexible wheeled stand with built-in charging capability for hands-free and mobile applications of the AV500/AV600 Vein Visualization System. Features adjustable height positioning, smooth arm rotation, break-away power cord, and lockable ergonomic stand wheels. Serviceable at the user's facility.
  • HF510 Pole Mount Arm Portable hands-free solution for the AV500 Vein Visualization System with a clamp attachment for rounded bedrails, IV poles, or flat surfaces. Includes quick-release device-holder and flexible arm design for adjustable positioning.
  • MRK-100 Vein Assessment Marker Medical-grade, FDA-registered disposable skin marking pen with EZ Removable Ink for non-surgical procedures including IV access. White colored ink is highly visible under near-infrared light; used to mark venous valves, bifurcations, and catheter insertion site locations. Latex free.
  • Platinum Service Plan Recurring service plan and warranty offering for AccuVein device maintenance, repair, and customer support, sold alongside AV500/AV600 vein visualization devices to healthcare facilities.

Quantifiable outcome

  • 78% reduction in PIV procedure time
  • +7 more outcomes

Companies that use AccuVein

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles4 records

AccuVein technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

AccuVein partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, strategic and minor.

  • Intalere (formerly Amerinet)coreChannel Partner/ Reseller/ DistributorAccuVein is an awarded supplier of Intalere, a Group Purchasing Organization, enabling contracted sales to Intalere member healthcare facilities.
  • VizientcoreChannel Partner/ Reseller/ DistributorAccuVein is an awarded supplier of Vizient, a Group Purchasing Organization, enabling contracted sales to Vizient member healthcare systems.
  • PremiercoreChannel Partner/ Reseller/ DistributorAccuVein is an awarded supplier of Premier, a Group Purchasing Organization, enabling contracted sales to Premier member healthcare facilities.
  • GSA AdvantagecoreChannel Partner/ Reseller/ DistributorAccuVein is an awarded supplier on GSA Advantage (contract V797P-4319B), enabling government healthcare facilities to purchase through federal supply schedules.
  • HealthtrustcoreChannel Partner/ Reseller/ DistributorAccuVein is an awarded supplier of Healthtrust, a Group Purchasing Organization, enabling contracted sales to Healthtrust member healthcare facilities.
  • Greiner Bio-OnestrategicOEM/ Whitelabel/ Licensing PartnerOriginal Equipment Manufacturer agreement with Greiner Bio-One to bring AccuVein's vein visualization technology to South American markets under the Greiner Bio-One AV400 Vein Scanner brand.
  • Emergo UL EuropeminorOthersEmergo UL Europe serves as AccuVein's authorized representative in Europe for regulatory compliance purposes.
  • Emergo AustraliaminorOthersEmergo Australia serves as AccuVein's authorized representative in Australia for regulatory compliance purposes.
  • Emergo Consulting (UK) LimitedminorOthersEmergo Consulting (UK) Limited serves as AccuVein's authorized representative in the United Kingdom for regulatory compliance purposes.
  • Association for Vascular Access (AVA)strategicStrategic or Co-development PartnerPartnership with AVA for continuing education programs, CE-accredited webinars, and annual scientific meeting presentations showcasing AccuVein technology and clinical evidence.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

AccuVein competitors and assessment

Company assessment

Direct peers

  • Christie Medical Holdings (VeinViewer): Manufacturer of the VeinViewer line of NIR-based vein visualization devices. Direct competitor to AccuVein's AV500/AV600, targeting the same hospital, non-acute, and aesthetics segments with similar handheld projection technology.
  • VueTek Scientific (Veinlite): Producer of Veinlite transillumination devices for vein access. Competes directly with AccuVein in phlebotomy, PIV access, and sclerotherapy use cases, with overlapping customer base of nurses, phlebotomists, and aesthetics practitioners.

Emerging players

  • NextVein: Emerging manufacturer of NIR vein visualization technology offering handheld vein finders to acute-care and outpatient facilities. A newer entrant competing on similar clinical use cases to AccuVein's AV series.
  • Illumivein: Smaller player in NIR vein visualization devices aimed at hospitals, blood draw centers, and aesthetics clinics. Competes in the same peripheral IV access niche as AccuVein with a more limited global footprint.
  • FUJIFILM Sonosite: Point-of-care ultrasound vendor increasingly used for guided peripheral IV access in hospitals. Represents a competing modality to AccuVein's NIR-based visualization in the difficult IV access workflow.

Broad incumbents

  • Becton, Dickinson and Company (BD): Global medical technology incumbent with a broad vascular access portfolio including PIVC catheters, ultrasound-guided IV systems, and integrated vein access solutions. Competes with AccuVein across the hospital vascular access workflow.
  • ICU Medical: Large incumbent in IV therapy, infusion systems, and vascular access. Overlaps with AccuVein's hospital PIV and infusion-center customer base and offers competing adjunct technologies like ultrasound guidance for difficult IV access.
  • Teleflex Incorporated: Major vascular access and interventional medical device company with a portfolio including PICC lines, central venous catheters, and difficult IV access solutions. Competes in the same clinical workflow as AccuVein.
  • Baxter International: Global medical products company (acquired AccuVein CEO Hutchison's prior company, Cheetah Medical). Competes in hospital infusion, IV therapy, and patient monitoring segments where AccuVein's vein visualization devices are deployed.
  • B. Braun Medical: Large medical device manufacturer with an extensive IV therapy, vascular access, and infusion portfolio. Serves the same hospital and non-acute customers that adopt AccuVein's vein visualization technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

AccuVein social profiles

Digital presence

AccuVein financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AccuVein leadership team

Management profile

Number of profiles

Profiles9 records

AccuVein funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AccuVein M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AccuVein

What does AccuVein do?

AccuVein designs, manufactures, and sells near-infrared (NIR) laser-based vein visualization medical devices that project a real-time map of superficial veins, valves, and bifurcations onto a patient's skin. Its core products are the AV500 and AV600 handheld vein illumination systems, complemented by hands-free stands (HF580), pole-mount arms (HF510), and disposable vein assessment markers (MRK-100). Devices are sold primarily to hospitals, non-acute care facilities, and aesthetic practices for peripheral IV access, phlebotomy, infusion therapy, and cosmetic injectables.

Is AccuVein a public or private company?

AccuVein is a private company. It is classified as venture growth investor backed and is currently operating.

When was AccuVein founded?

AccuVein was founded in 2009. It employs 101 to 250 people.

Where is AccuVein based?

AccuVein is headquartered in Medford, United States, in the North America region.

How does AccuVein make money?

Four revenue lines are on record. Vein Visualization Device Sales are the primary driver. The others are accessories and Consumables, service Plans and short-term Rentals.

Who are AccuVein's main competitors?

Direct peers on record are Christie Medical Holdings (VeinViewer) and VueTek Scientific (Veinlite). Emerging players are NextVein, Illumivein and FUJIFILM Sonosite. Broad incumbents are Becton, Dickinson and Company (BD), ICU Medical, Teleflex Incorporated, Baxter International and B. Braun Medical.

Does AccuVein have an API?

No public API is recorded for AccuVein.

What industry is AccuVein in?

AccuVein's product category is Medical Devices (Vein Visualization). Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device and Diagnostic industryVein Finding Can Be IlluminatingAccuVein Inc. has developed the AV400, a handheld vein illumination system that uses infrared laser technology to project vein maps onto a patient's skin for improved medical procedure accuracy. The device was selected as a finalist for the Medical Design Excellence Awards and addresses previous generation limitations through advanced digital signal processing and adaptive algorithms. Development involved collaboration with Zietlow Design for hardware engineering and Aequorix Scientific Ltd. for embedded software to ensure safety and performance.TorrancememorialTechnology Offers Relief from Needle SticksTorrance Memorial has acquired the AccuVein AV400 vein visualization system to improve first-stick success rates and reduce patient pain during venipuncture. The device helps healthcare professionals locate veins beneath the skin, addressing the issue where up to one-third of vein access attempts fail initially.InappstoryExploring the Revolutionary Impact of AR in Mobile Apps and MarketingThe article analyzes the transformative impact of Augmented Reality (AR) on mobile applications and marketing, highlighting its evolution from research labs to mainstream use via advanced smartphone sensors. It details specific industry applications, such as Pokémon GO in gaming, IKEA Place in retail, and AccuVein in healthcare, while noting that 5G connectivity and AI are driving future advancements. The piece concludes by discussing challenges related to hardware requirements, privacy, and ethical considerations associated with data collection.openPR.comUnited States Virtual and Augmented Reality in Healthcare Market Industry Outlook & Key Players Insights | Major Players 2025 - F. Hoffmann-La Roche Ltd, CAE Inc., EON Reality, Inc.,The global VR/AR healthcare market was valued at $3.57B in 2023, grew to $4.10B in 2024, and is projected to reach $15.06B by 2033 (CAGR 15.4%). Recent 2025 launches include Medtronic's AR surgical platform, Osso VR's training system, and AccuVein's vascular access system.EMS1How paramedics can use vein finder devices like the AccuVein to improve IV accessThe article details the use of AccuVein and similar infrared vein finder devices to help paramedics improve intravenous access success rates in difficult cases. It highlights the device's ability to visualize veins via laser technology, reducing failed insertion attempts and speeding up patient care. The piece also provides specific product information for the AccuVein AV500, including its features and a listed price of $4,895.Lumexr7 Augmented Reality Display Trends Transforming Industries in 2024The article outlines seven emerging trends in augmented reality displays, including supersized screens, advanced wearables like AR glasses and contact lenses, and the integration of artificial intelligence for personalized interactions. It highlights specific technologies and companies such as Meta, Apple Vision Pro, XPANCEO, AccuVein, and Varjo that are driving innovation across retail, healthcare, education, and automotive sectors. The piece projects significant growth in mobile AR users by 2028 and emphasizes the transition of AR from novelty to indispensable professional and consumer tool.PR NewswireAging Population and Rising Chronic Disease Incidence Propel Global Vein Illumination Technologies Market to 2030ResearchAndMarkets has published a strategic business report on the global vein illumination technologies market, projecting significant growth driven by aging populations and rising chronic disease incidence. The U.S. market is estimated at US$63.4 million in 2022, while China is forecast to reach US$106.2 million by 2030 with a 35% CAGR. Key competitors identified in the sector include AccuVein Inc., Christie Medical Holdings, Inc., and Braun Medical Inc.Business Wire BlogAccuVein to Showcase its True Center™ Technology and Sponsor Symposium at AVA 2022AccuVein Inc. is showcasing its AV500 vein visualization device, featuring patented True Center™ technology, at the Association for Vascular Access (AVA) 2022 Annual Scientific Meeting in Minneapolis. The company is also sponsoring a symposium on peripheral IV access best practices, aiming to demonstrate how the technology reduces blind sticks and improves clinical efficiency.KadimaluzerneHow Augmented Reality Will Impact the Medical FieldAugmented reality is applied in healthcare through apps and devices like AED4EU, Accuvein, and HoloAnatomy. Accuvein, a vein-finding scanner, improved first-attempt vein access odds by 3.5 times after over 10 million uses. HoloAnatomy provides 3D anatomical visualization for medical education and remote presentations.SecSEC FORM DAccuVein Inc. filed a Form D with the SEC regarding an exempt offering of securities, claiming a Rule 506(b) exemption. The company reported a total offering amount of $18,293,520 USD, with $17,296,753 USD already sold to 36 investors as of July 31, 2020. This filing serves as a regulatory notice for the private placement of equity securities.